What is the market doing?
What the tape says about PFE
Pfizer is +24% over the past year while the S&P 500 is +23%: 1.9 points ahead of the market.
+24%
1-year return · S&P 500 +23%
- vs 200-day average
- +11%
vs 200-day average · a clear uptrend
- RSI (14)
- 72
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −0.86%
Below its 52-week high
Details›
- Last close2026-08-26
- $28.32
- 1 monthS&P 500 +3.7%
- +13%
- 1 yearS&P 500 +23%
- +24%
- 5 yearsS&P 500 +87%
- −15%
- vs 50-day average$25.89
- +9.4%
- 52-week high
- $28.57
- 52-week low
- $22.44
- Annualised volatility
- 24%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$51K
| Year | Return |
|---|---|
| 2026 (year to date) | +18% |
| 2025 | +0.65% |
| 2024 | −2.2% |
| 2023 | −41% |
| 2022 | −10% |
| 2021 | +67% |
| 2020 | +3.1% |
| 2019 | −6.9% |
| 2018 | +25% |
| 2017 | +16% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | −2.5% |
| Feb | 10 | 3 of 10 | −2.4% |
| Mar | 10 | 6 of 10 | +1.5% |
| Apr | 10 | 3 of 10 | −0.40% |
| May | 10 | 5 of 10 | +2.0% |
| Jun | 10 | 5 of 10 | −1.7% |
| Jul | 11 | 6 of 11 | +3.9% |
| Aug | 11 | 5 of 11 | +0.23% |
| Sep | 10 | 4 of 10 | −0.66% |
| Oct | 10 | 3 of 10 | −1.2% |
| Nov | 10 | 9 of 10 | +6.5% |
| Dec | 10 | 5 of 10 | −0.23% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #14 of 16 by Smart Score